CardiaCare receives IRB and MOH approval to commence it’s first in human atrial fibrillation study in Sheba Medical Center Israel
© 2022 CardiaCare. All right reserved. | Ux & Ui By Studiomelamed.com
CardiaCare receives IRB and MOH approval to commence it’s first in human atrial fibrillation study in Sheba Medical Center Israel
Comments are closed.
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.